Literature DB >> 2892856

Antiserum to scrapie-associated fibril protein cross-reacts with Spiroplasma mirum fibril proteins.

F O Bastian1, R A Jennings, W A Gardner.   

Abstract

Protease-resistant fibril proteins purified from Spiroplasma mirum and from Creutzfeldt-Jakob disease-infected brain tissues reacted with antisera to scrapie-associated fibrils on Western immunoblot analysis. These data suggest that there are conformational similarities among spiroplasma proteins and infection-specific proteins of the transmissible spongiform encephalopathies.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2892856      PMCID： PMC269511          DOI： 10.1128/jcm.25.12.2430-2431.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

Review 1.  Scrapie, an unconventional virus: the current views.

Authors:  H K Narang
Journal:  Proc Soc Exp Biol Med       Date:  1987-04

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Additional evidence of spiroplasma in Creutzfeldt-Jakob disease.

Authors:  F O Bastian; M N Hart; P A Cancilla
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

4.  Spiroplasma and Creutzfeldt-Jakob disease.

Authors:  A Gray; R J Francis; C L Scholtz
Journal:  Lancet       Date:  1980-07-19       Impact factor: 79.321

5.  Abnormal fibrils from scrapie-infected brain.

Authors:  P A Merz; R A Somerville; H M Wisniewski; K Iqbal
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

6.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

Review 7.  The genus Spiroplasma.

Authors:  R F Whitcomb
Journal:  Annu Rev Microbiol       Date:  1980       Impact factor: 15.500

8.  Neuropathology of spiroplasma infection in the rat brain.

Authors:  F O Bastian; D M Purnell; J G Tully
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

9.  Intracellular spiral inclusions in cerebral cell processes in Creutzfeldt-Jakob disease.

Authors:  J M Reyes; E M Hoenig
Journal:  J Neuropathol Exp Neurol       Date:  1981-01       Impact factor: 3.685

10.  Spiroplasma-like inclusions in Creutzfeldt-Jakob disease.

Authors:  F O Bastian
Journal:  Arch Pathol Lab Med       Date:  1979-12       Impact factor: 5.534
View more
  5 in total

1.  Evaluation of [3H]thymidine uptake method for studying growth of spiroplasmas under various conditions.

Authors:  F O Bastian; B S Baliga; H M Pollock
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

2.  Experimental inoculation of raccoons (Procyon lotor) with Spiroplasma mirum and transmissible mink encephalopathy (TME).

Authors:  Amir N Hamir; Justin J Greenlee; Thad B Stanton; Jodi D Smith; Stephanie Doucette; Robert A Kunkle; Judith A Stasko; Juergen A Richt; Marcus E Kehrli
Journal:  Can J Vet Res       Date:  2011-01       Impact factor: 1.310

3.  Identification and characterization of proteinase K-resistant proteins in members of the class Mollicutes.

Authors:  G H Butler; H Kotani; L Kong; M Frick; S Evancho; E J Stanbridge; G J McGarrity
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

4.  African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxin.

Authors:  Kumar Sachin Singh; Julia I-Ju Leu; Thibaut Barnoud; Prashanthi Vonteddu; Keerthana Gnanapradeepan; Cindy Lin; Qin Liu; James C Barton; Andrew V Kossenkov; Donna L George; Maureen E Murphy; Farokh Dotiwala
Journal:  Nat Commun       Date:  2020-01-24       Impact factor: 14.919

Review 5.  Reflections on scrapie and related disorders, with consideration of the possibility of a viral aetiology.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.